Search
SOLACI Congress
Seventh Series 2012 - SOLACI 2012, Mexico D.F, Mexico

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

solaci
solaci
116
0

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Previous article
Use of FFR Dr. David R. Holmes
Next article
Grandes estudios en enfermedad coronaria: COURAGE, FAME y SYNTAX Dr. Conrad Simpfendorfer – Heart & Vascular Institute Cleveland Clinic – Estados Unidos
solaci
solaci

More articles by this author

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

solaci - 0
Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

solaci - 0
Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

solaci - 0
Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

solaci - 0
Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Seventh Series 2012 - SOLACI 2012, Mexico D.F, Mexico

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD
solaci -
SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

Dr. Omar Tupayachi - 0
In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Dr. Omar Tupayachi - 0
Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Dr. Omar Tupayachi - 0
Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

Dr. Omar Tupayachi - 0
In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Dr. Omar Tupayachi - 0
Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Dr. Omar Tupayachi - 0
Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Institutional News

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

solaci - 0
You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy